<DOC>
	<DOCNO>NCT00542620</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial compare two method injection basal-bolus insulin regimen child type 1 diabetes insulin detemir associate insulin aspart give twice daily either separate mixed injection investigate clinical impact choose one regimen another .</brief_summary>
	<brief_title>Comparison Insulin Detemir Insulin Aspart 2 Separate Injections Twice Daily Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Parents ' Informed Consent ( IC ) obtain trialrelated activity Obtained child 's assent ( possible ) Type 1 diabetes Treatment insulin detemir insulin aspart either extemporaneous mixed separate injection HbA1c ( glycosylated haemoglobin A1c ) lesser equal 8.6 % History alcoholism , drug abuse , psychiatric disease personality disorder likely invalidate voluntary consent prevent good compliance trial protocol Mental incapacity , unwillingness language barrier preclude adequate understanding cooperation Anticipated change new use concomitant medication know interfere glucose metabolism , systemic corticotherapy 5 mg/day ( prednisone ) Any condition Investigator ( trial physician ) feel would interfere trial participation evaluation result</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>